Suturion is a pioneering brand that is transforming surgical wound closure with its revolutionary products. Dedicated to innovation, Suturion offers groundbreaking solutions that are reshaping the suturing process in surgical procedures. At Suturion, the focus is on hernia prevention, and they are committed to developing a new suturing choice for abdominal wall closure.

The brand's story began with Gabriel Börner, a visionary surgeon who encountered complications after open abdominal surgeries. Determined to make a difference, Börner collaborated with medtech engineer Mats O. Christensson and LU Holding AB to establish Suturion AB in 2018. Since then, Suturion has filed multiple patent applications, conducted extensive market analysis, and undertaken pre-clinical research.

Supported by scientific evidence and a passion for patient well-being, Suturion aims to help surgeons prevent hernias rather than solely repairing them. Gabriel Börner, a renowned speaker and researcher, shares his scientific findings worldwide.

In 2022, Suturion will embark on a crucial clinical trial, bringing them closer to receiving regulatory approval from CE and FDA. Stay updated on the latest advancements by signing up for their newsletter. With Suturion, the future of surgical wound closure is being reshaped.